Your search history is turned on.
Date: April 29, 2024 Jurisdictions: Alberta, British Columbia, Ontario
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ZYUS ANNOUNCES ANTICIPATED DELAY IN ITS ANNUAL FILINGS Saskatoon, Saskatchewan, April 29, 2024 ZYUS Life Sciences Corporation (ZYUS or the Company) (TSXV: ZYUS) today announces that, as a result of a delay by the Companys auditor, KPM...
Date: April 23, 2024 Jurisdictions: Alberta, British Columbia, Ontario
ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management ZYUS Receives Patent from United States Patent and Trademark Office (USPTO) Supporting ZYUS Lead Drug Candidate SASKATOON, Saskatchewan April 23, 2024 -- ZYUS Life Sciences Corporation (the Company) (TSX-V: ZYUS), a Canadian-base...
Date: April 12, 2024 Jurisdictions: Alberta, British Columbia, Ontario
VIA ELECTRONIC TRANSMISSION TO ALL APPLICABLE EXCHANGES AND COMMISSIONS: RE: ZYUS LIFE SCIENCES CORPORATION Confirmation of Notice of Record and Meeting Dates We are pleased to confirm that Notice of Record and Meeting Dates was sent to The Canadian Depository for Securities. We advise the following with respect to the upcoming Annual General and Special Meetin...
Date: February 1, 2024 Jurisdictions: Alberta, British Columbia, Ontario
ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke Dr. Clarke Joins ZYUS Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management SASKATOON, Saskatchewan February 1, 2024 -- ZYUS Life Sciences Corporation (the Company) (TSX-V: ZYUS), a C...
Date: January 9, 2024 Jurisdictions: Alberta, British Columbia, Ontario
ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS experienced team SASKATOON, Saskatchewan January 9, 2024 -- ZYUS Life Sciences Corporation (the Company) (TSX- V: ZYUS), a Canadian-based life scienc...
Date: January 2, 2024 Jurisdictions: Saskatchewan
Create report of exempt distribution (Form 45-106F1) Form 45-106F1 Report of Exempt Distribution ITEM 1 - REPORT TYPE New report Amended report If amended, provide filing date of report that is being amended. (YYYY-MM-DD) ITEM 2 - PARTY CERTIFYING THE REPORT Indicate the party certifying the report (select only one). For guidance regarding whether an ...
Date: December 22, 2023 Jurisdictions: Alberta, British Columbia, Ontario
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ZYUS Life Sciences Corporation Announces Issuance of Shares for Debt Settlement Toronto, Ontario, December 22, 2023 ZYUS Life Sciences Corporation (the Company) is pleased to announce that it has entered into a debt exchange agreement to settle a certain ...
Date: December 5, 2023 Jurisdictions: Alberta, British Columbia, Ontario
ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin Softgel Capsules for Advanced Cancer Pain Management Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain SASKATOON, Saskatchewan December 5, 2023 ZYUS Life Sciences Corporation ("ZYUS" or th...
Date: November 29, 2023 Jurisdictions: Alberta, British Columbia, Ontario
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES ZYUS Life Sciences Corporation Reports Q3 2023 Results Completed evaluation of and restated Q2 2023 interim financial statements SASKATOON, Saskatchewan November 29, 2023 -- ZYUS Life Sciences Corporation ("ZYUS" or the Company) (TSX-V: ...
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, John Hyshka, Chief Financial Officer of ZYUS Life Sciences Corporation, certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of ZYUS Life Sciences Corporation (the issuer)...